Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 2:39 pm Sale | 13G | IONIS PHARMACEUTICALS INC IONS | BB BIOTECH AG | 7,994,955 5.7% | -746,379 (-8.54%) | View |
2020-02-14 2:36 pm Purchase | 13G | ESPERION THERAPEUTICS INC ESPR | BB BIOTECH AG | 3,727,964 13.6% | 335,000 (+9.87%) | View |
2020-02-14 2:35 pm Purchase | 13G | AGIOS PHARMACEUTICALS INC AGIO | BB BIOTECH AG | 3,896,954 5.7% | 918,820 (+30.85%) | View |
2020-02-14 2:35 pm Unchanged | 13G | CIDARA THERAPEUTICS INC CDTX | BB BIOTECH AG | 2,295,272 6.9% | 0 (Unchanged) | View |
2020-02-06 2:29 pm Purchase | 13G | INTRA-CELLULAR THERAPIES INC. ITCI | BB BIOTECH AG | 3,458,419 5.3% | 1,258,419 (+57.20%) | View |
2020-01-29 4:34 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | BB BIOTECH AG | 2,161,152 5.03% | 2,161,152 (New Position) | View |
2019-12-23 5:06 pm Purchase | 13G | WAVE LIFE SCIENCES LTD WVE | BB BIOTECH AG | 1,902,858 5.5% | 1,902,858 (New Position) | View |